Organon (OGN) Change in Inventory (2020 - 2026)
Organon (OGN) posted quarterly Change in Inventory of $9.0 million for Q1 2026, up 400.0% year-over-year from $1.8 million in Q1 2025, and up 111.11% on a QoQ basis from -$81.0 million in Q4 2025.
Organon (OGN) Change in Inventory (2020 - 2026) Analysis & Trends
Organon (OGN) has reported Change in Inventory for 7 consecutive years, with $9.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Inventory rose 400.0% year-over-year to $9.0 million; the TTM figure through Mar 2026 stood at $25.0 million (down 82.99% YoY), while the FY2025 annual figure was $13.0 million, down 90.08% from the prior year.
- Change in Inventory came in at $9.0 million for Q1 2026 at Organon, up from -$81.0 million in the prior quarter.
- The five-year high for Change in Inventory was $95.0 million in Q2 2022, with the low at -$81.0 million in Q4 2025.
- Average Change in Inventory over 5 years is $35.5 million, with a median of $38.0 million recorded in 2023.
- Across the five-year window, Change in Inventory tumbled 361.29% in 2025 and soared 400.0% in 2026, its largest moves.
- Year by year, Change in Inventory stood at $86.0 million in 2022, then climbed by 8.14% to $93.0 million in 2023, then plunged by 66.67% to $31.0 million in 2024, then tumbled by 361.29% to -$81.0 million in 2025, then surged by 111.11% to $9.0 million in 2026.
- According to Business Quant data, Change in Inventory over the past three periods registered $9.0 million, -$81.0 million, and $63.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | - |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 431.00 Mn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 184.00 Mn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | - |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | - |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | -18.00 Mn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 52.00 Mn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | - |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Organon | 3.53 Bn | 2.41 Bn | 783.00 Mn | 9.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.00 Mn |
| Mar 31, 2026 | 9.00 Mn |
| Dec 31, 2025 | -81.00 Mn |
| Dec 31, 2025 | -81.00 Mn |
| Sep 30, 2025 | 63.00 Mn |
| Sep 30, 2025 | 63.00 Mn |
| Jun 30, 2025 | 34.00 Mn |
| Jun 30, 2025 | 34.00 Mn |
| Mar 31, 2025 | -3.00 Mn |
| Mar 31, 2025 | -3.00 Mn |
| Dec 31, 2024 | 31.00 Mn |
| Dec 31, 2024 | 31.00 Mn |
| Sep 30, 2024 | 61.00 Mn |
| Sep 30, 2024 | 61.00 Mn |
| Jun 30, 2024 | 58.00 Mn |
| Jun 30, 2024 | 58.00 Mn |
| Mar 31, 2024 | -19.00 Mn |
| Mar 31, 2024 | -19.00 Mn |
| Dec 31, 2023 | 93.00 Mn |
| Dec 31, 2023 | 93.00 Mn |